Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

392 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retrospective study on thymidylate synthase as a predictor of outcome and sensitivity to adjuvant chemotherapy in patients with curatively resected colorectal cancer.
Sugiyama Y, Kato T, Nakazato H, Ito K, Mizuno I, Kanemitsu T, Matsumoto K, Yamaguchi A, Nakai K, Inada K, Tatematsu M. Sugiyama Y, et al. Among authors: nakazato h. Anticancer Drugs. 2002 Oct;13(9):931-8. doi: 10.1097/00001813-200210000-00005. Anticancer Drugs. 2002. PMID: 12394256 Clinical Trial.
Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial.
Kato T, Ohashi Y, Nakazato H, Koike A, Saji S, Suzuki H, Takagi H, Nimura Y, Hasumi A, Baba S, Manabe T, Maruta M, Miura K, Yamaguchi A. Kato T, et al. Among authors: nakazato h. Langenbecks Arch Surg. 2002 Mar;386(8):575-81. doi: 10.1007/s00423-002-0278-x. Epub 2002 Feb 28. Langenbecks Arch Surg. 2002. PMID: 11914933 Clinical Trial.
Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer.
Saji S, Sakamoto J, Teramukai S, Kunieda K, Sugiyama Y, Ohashi Y, Nakazato H. Saji S, et al. Among authors: nakazato h. Surg Today. 1999;29(6):504-10. doi: 10.1007/BF02482344. Surg Today. 1999. PMID: 10385364 Clinical Trial.
A phase III randomized study comparing doxifluridine and 5-fluorouracil as supportive chemotherapy in advanced and recurrent gastric cancer.
Kondo K, Sakamoto J, Nakazato H, Koike A, Kitoh T, Hachisuka K, Saji S, Yura J, Nimura Y, Hamajima N, Katoh K, Yamaguchi A, Miya KI, Yamauchi M, Mizuno I, Nagino M, Takagi H. Kondo K, et al. Among authors: nakazato h. Oncol Rep. 2000 May-Jun;7(3):485-90. doi: 10.3892/or.7.3.485. Oncol Rep. 2000. PMID: 10767356 Clinical Trial.
An individual patient data meta-analysis of long supported adjuvant chemotherapy with oral carmofur in patients with curatively resected colorectal cancer.
Sakamoto J, Kodaira S, Hamada C, Ito K, Maehara Y, Takagi H, Sugimachi K, Nakazato H, Ohashi Y; Meta-Analysis Group of the Japanese Society of Strategies for Cancer Research and Therapy. Sakamoto J, et al. Among authors: nakazato h. Oncol Rep. 2001 May-Jun;8(3):697-703. Oncol Rep. 2001. PMID: 11295105
Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up.
Ito K, Nakazato H, Koike A, Takagi H, Saji S, Baba S, Mai M, Sakamoto J, Ohashi Y; Study Group of Immunochemotherapy with PSK for Colon Cancer. Ito K, et al. Among authors: nakazato h. Int J Colorectal Dis. 2004 Mar;19(2):157-64. doi: 10.1007/s00384-003-0532-x. Epub 2003 Sep 12. Int J Colorectal Dis. 2004. PMID: 13680286 Clinical Trial.
392 results